SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-001540
Filing Date
2021-01-05
Accepted
2021-01-05 08:15:28
Documents
3
Period of Report
2021-01-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d17734d8k.htm 8-K 19500
2 EX-99.1 d17734dex991.htm EX-99.1 25585
3 GRAPHIC g17734new-sp5.jpg GRAPHIC 2556
  Complete submission text file 0001193125-21-001540.txt   49960
Mailing Address 4500 GREAT AMERICAN PARKWAY SUITE 100 #29 SANTA CLARA CA 95054
Business Address 4500 GREAT AMERICAN PARKWAY SUITE 100 #29 SANTA CLARA CA 95054 650-800-6676
Vincera Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 21503958
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences